pneumoconiosis market is expected to offer significant growth at a CAGR of 9.4%

1. Contrive Datum InsightsGlobal Research And Consulting A complete solution to explore all the potential aspect to drive the growth of the business industries. Pneumoconiosis Market

2. About Us Contrive Datum Insights (CDI) is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. CDI’s experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyse information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each CDI syndicated research report covers a different sector — such as chemicals, materials, metals & mining, pharmaceuticals, energy, automotive, food and beverages, semiconductors, med-devices, consumer goods and information technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.

3. Services Offered : • Market Intelligence & Market Opportunity Assessment • Market Size & Segmentation • Market Entry Strategy • Competitor Benchmarking • Pricing Intelligence • Customer Intelligence • Sourcing Intelligence • New-Generation Products & Technologies • Distribution & Sales Channel Assessment

4. Clientele: Some of the global leading clients that we have served:

5. Clientele: Some of the global leading clients that we have served:

6. MarketOverview The pneumoconiosis market is expected to reach USD 2,280.88 million by 2030, with a 9.40% CAGR during the projection period.Pneumoconiosis is a restrictive lung disease caused by breathing in dust at work. When breathed, a number of different things can cause pneumoconiosis. Both living and nonliving things are to blame for this disease. According to the Centers for Disease Control and Prevention (CDC), 260,000 people died of pneumoconiosis in 2013. Pneumoconiosis is becoming more common, more people are smoking, and air pollution is getting worse, all of which are driving the rise of the market. About 75% of the cases of non-asbestos pneumoconiosis reported by the IIDB scheme in 2009 were in people over 65 years old. According to the Centers for Disease Control and Prevention, cigarette smoking is the top cause of death in the United States, causing more than 480,000 deaths every year.

7. By Region: The United States has more people with pneumoconiosis than any other country. Aside from this, the U.S. market is growing because there are more patients, their habits are changing, and they are spending more on healthcare. According to the Centers for Disease Control and Prevention, about 15 out of every 100 people over 18 in the U.S. smoked in 2015. This means that about 36.5 million people in the U.S. smoke at the moment. This disease is more likely to happen if there are more people who smoke. The market is also growing because more people are learning about different diagnostic methods and new technologies.Asia-Pacific is the biggest market for pneumoconiosis, followed by Europe. The market will be driven by the number of smokers, the amount of money available for study, and the government's support for research and development.Asia-Pacific is the fastest-growing market region because it has a large number of patients, a growing economy, and a lot of possibilities.

8. The Global Pneumoconiosis Market has been segmented into: • By Type: • Asbestosis • Berylliosis • Byssinosis • Coal Workers Pneumoconiosis • Silicosis • Others • Treatment Type • Mucolytic Agent • Antibiotic • Others • Route of Administration • Oral • Inhalation • Others • End Users • Hospitals • Homecare • Specialty Clinics • Others

9. The Global Pneumoconiosis Market has been segmented into: • By Region • Europe • Germany • France • Italy • Spain • UK • Nordic Countries • Denmark • Finland • Iceland • Sweden • Norway • Benelux Union • Belgium • The Netherlands • Luxembourg • Rest of Europe • By Region • North America • US • Canada • Mexico • Rest of North America • The Middle East & Africa • Saudi Arabia • UAE • Egypt • South Africa • Rest of the Middle East & Africa • Latin America • Brazil • Argentina • Rest of Latin America • ByRegion • Asia-Pacific • Japan • China • India • Australia • South Korea • Southeast Asia • Indonesia • Thailand • Malaysia • Singapore • Rest of Southeast Asia • Rest of Asia-Pacific

10. Key Market Updates: Pneumoconiosis can happen when a person breathes in dust particles such as asbestos, coal dust, or silica. If these particles get into the lungs' passageways or air sacs, the body will try to fight them off by making them red and swollen. Since there is no cure for pneumoconiosis yet, treatment works on managing symptoms and keeping the disease from getting worse. The treatment plan for this disease includes oxygen therapy, bronchodilators, antibiotics, and a mucolytic agent. Bronchodilators are used to treat breathing problems, while corticosteroids can help with congestion.The rise in the number of people who smoke around the world will be a big factor in increasing the growth rate of the market. In the United States, cigarette smoking is the main cause of preventable disability, disease, and even death, causing about 480,000 deaths each year. In the United States, nearly 13 out of every 100 people aged 18 and up (12.5 percent) have smoked cigarettes in 2020. In the United States, this means that about 30.8 million adults smoke. More than 16 million Americans have a disorder linked to smoking.

11. Market Players • Novartis • Abbott • Eli Lilly • Sunpharma • Sanofi • Novo Nordisk • others.

12. Customer Experiences “Very happy with the service. Report quality as well as response time for my custom market study was great. I am looking forward to work with Contrive Datum Insights (CDI) in future. “ “We are satisfied with research report offered by Contrive Datum Insights (CDI) .” We appreciate your support throughout the project.” "You and your team did a terrific job on this project.” CDI will be at the top of our list in the future for market research projects.” G. Luca, A+ Outsourced Marketing Consulting Company (privacy requested) Europe based Fortune 500 Company (privacy requested)

13. By associating with Contrive Datum Insights (CDI) , customer can enjoy following benefits: • One-Stop-Destination for all research needs (Syndicate and Custom Reports) • Reduced Budget and Faster Turnaround Time • Focused Research Team - Contrive Datum Insights (CDI) can arrange a dedicated team of 2-3 resources with 1 Research Manager , who will look after any ad-hoc needs of the client • Dedicated Account Manager • 24/7 availability for any custom needs of the client • Flexible Partnering Model to accommodate client’s research needs • Access to Data-Cuts related to required Market for global region • ▪ Industry Update on Weekly/Bi-Weekly/Monthly basis • ▪ Market Trend Analysis on Monthly/Quarterly basis Benefits of Association

14. Thank You! To know more about us, please visit our website: www.contrivedatuminsights.com For sales queries or new topics email us on: anna@contrivedatuminsights.com